Retagliptin
Product Detail
Product Tags
| Pack Size | Availability | Pretium (USD) |
Nomen chemicum:
(R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine- I-phosphate carboxylate
SMILES Code:
COC(C1=NC([N]2=C1CN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)C (F)(F)=O
InChi Code:
InChI=1S/C19H19F6N4O3/c1-32-17(31)16-14-8-28(2-3-29(14)18(27-16)19(23,24)25)15(30)6- 10(26)4-9-5-12(21)13(22)7-11(9)20/h5,7,10,18H,2-4,6,8,26H2,1H3/t10-,18 ?/m1/s1
InChi Key:
FXBCTRLEFVUDDC-DMPGVRBJSA-N
Keyword:
Retagliptin, SP-2086,SP2086,1174122-54-3, 1256756-88-3
Solubilitas:Solutum in DMSO
Repono:0 - 4°C ad terminum brevem (dies ad septimanas), vel -20°C ad terminum longi (menses).
Descriptio:
Retagliptin, etiam quae SP-2086 nota est, inhibitor DPP-IV potentialiter ad tractationem diabetarum Typus 2 diabetarum adhibitus est.
Target: DPP-4
